The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee

Immunity to solid tumors is associated with the hallmarks of cancer-associated inflammation and the ability of immune mechanisms to limit tumor progression. Application of expanded tumor-infiltrating lymphocyte adoptive T cell therapy (TIL ACT) in clinical trials is now practiced at many sites aroun...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Marco Donia, Nicholas P Restifo, Alena Gros, Simon Turcotte, Brian R Gastman, George Coukos, Alexandre Harari, James C Yang, Michael T Lotze, Fumito Ito, Pranav Murthy, Stephanie L Goff, Sara I Pai, Sangeetha Prabhakaran, John E Mullinax, Patrick L Wagner, Natalie L Silver, Sophia Hernandez, Ajay V Maker, Paula Marincola Smith
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	BMJ Publishing Group 2025-11-01
Sraith:	Journal for ImmunoTherapy of Cancer
Rochtain ar líne:	https://jitc.bmj.com/content/13/11/e013420.full
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee

Míreanna comhchosúla